Terms: = Lung cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Clinical Outcome
5 results:
1. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM
J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122
[TBL] [Abstract] [Full Text] [Related]
2. Nanoparticle Delivery of miR-708 Mimetic Impairs Breast cancer Metastasis.
Ramchandani D; Lee SK; Yomtoubian S; Han MS; Tung CH; Mittal V
Mol Cancer Ther; 2019 Mar; 18(3):579-591. PubMed ID: 30679387
[TBL] [Abstract] [Full Text] [Related]
3. Two-stage induced differentiation of oct4+/Nanog+ stem-like cells in lung adenocarcinoma.
Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
[TBL] [Abstract] [Full Text] [Related]
4. The oncofetal protein IMP3: a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung.
Del Gobbo A; Vaira V; Guerini Rocco E; Palleschi A; Bulfamante G; Ricca D; Fiori S; Bosari S; Ferrero S
J Thorac Oncol; 2014 Nov; 9(11):1656-61. PubMed ID: 25144243
[TBL] [Abstract] [Full Text] [Related]
5. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
[TBL] [Abstract] [Full Text] [Related]